Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Maria Laura, De Angelis"'
Autor:
Maria Laura De Angelis, Federica Francescangeli, Eleonora Aricò, Paola Verachi, Massimo Zucchetti, Cristina Matteo, Elena Petricci, Emanuela Pilozzi, Isabella Orienti, Alessandra Boe, Adriana Eramo, Rachele Rossi, Tiberio Corati, Daniele Macchia, Anna Maria Pacca, Ann Zeuner, Marta Baiocchi
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-20 (2024)
Abstract Background Prevention and treatment of metastatic breast cancer (BC) is an unmet clinical need. The retinoic acid derivative fenretinide (FeR) was previously evaluated in Phase I-III clinical trials but, despite its excellent tolerability an
Externí odkaz:
https://doaj.org/article/5942086ad2e94655b5f65ad924876c24
Autor:
Iole Macchia, Valentina La Sorsa, Alessandra Ciervo, Irene Ruspantini, Donatella Negri, Martina Borghi, Maria Laura De Angelis, Francesca Luciani, Antonio Martina, Silvia Taglieri, Valentina Durastanti, Maria Concetta Altavista, Francesca Urbani, Fabiola Mancini
Publikováno v:
Biomolecules, Vol 14, Iss 10, p 1217 (2024)
COVID-19 remains a significant threat, particularly to vulnerable populations. The emergence of new variants necessitates the development of treatments and vaccines that induce both humoral and cellular immunity. This study aimed to identify potentia
Externí odkaz:
https://doaj.org/article/d70778cc12cb480894b4c98047553a86
Autor:
Martina Borghi, Alessandra Gallinaro, Maria Franca Pirillo, Andrea Canitano, Zuleika Michelini, Maria Laura De Angelis, Serena Cecchetti, Antonella Tinari, Chiara Falce, Sabrina Mariotti, Antonio Capocefalo, Maria Vincenza Chiantore, Angelo Iacobino, Antonio Di Virgilio, Marit J. van Gils, Rogier W. Sanders, Alessandra Lo Presti, Roberto Nisini, Donatella Negri, Andrea Cara
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Several COVID-19 vaccine strategies utilizing new formulations for the induction of neutralizing antibodies (nAbs) and T cell immunity are still under evaluation in preclinical and clinical studies. Here we used Simian Immunodeficiency Virus (SIV)-ba
Externí odkaz:
https://doaj.org/article/d6a90457e0554050aaece8683c609075
Autor:
Maria Laura De Angelis, Federica Francescangeli, Chiara Nicolazzo, Michele Signore, Alessandro Giuliani, Lidia Colace, Alessandra Boe, Valentina Magri, Marta Baiocchi, Antonio Ciardi, Francesco Scarola, Massimo Spada, Filippo La Torre, Paola Gazzaniga, Mauro Biffoni, Ruggero De Maria, Ann Zeuner
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-15 (2022)
Abstract Background Circulating tumor cells (CTCs) are responsible for the metastatic dissemination of colorectal cancer (CRC) to the liver, lungs and lymph nodes. CTCs rarity and heterogeneity strongly limit the elucidation of their biological featu
Externí odkaz:
https://doaj.org/article/d558e197a70349ccafa097cd3b68c930
Autor:
Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo, Monica Tolazzi, Martina Borghi, Cristina Brigatti, Maria Laura De Angelis, Marco Baratella, Elena Bazzigaluppi, Giulietta Venturi, Francesca Sironi, Andrea Canitano, Ilaria Marzinotto, Cristina Tresoldi, Fabio Ciceri, Lorenzo Piemonti, Donatella Negri, Andrea Cara, Vito Lampasona, Gabriella Scarlatti
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Antibody responses are critical for protection from developing severe COVID-19 following SARS-CoV-2 infection. Here the authors show that antibody responses against SARS-CoV-2 spike protein correlate with neutralizing capacity and protection, are not
Externí odkaz:
https://doaj.org/article/d80ed3f91a004c7c8f240e8633323310
Autor:
Maria Laura De Angelis, Federica Francescangeli, Chiara Nicolazzo, Eljona Xhelili, Filippo La Torre, Lidia Colace, Alessandro Bruselles, Daniele Macchia, Sara Vitale, Paola Gazzaniga, Marta Baiocchi, Ann Zeuner
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Metastasis is the primary cause of death in patients with colorectal cancer (CRC), urging the need for preclinical models that recapitulate the metastatic process at the individual patient level. We used an orthotopic patient-derived xenograft (PDX)
Externí odkaz:
https://doaj.org/article/625f39741d3243fcbdc5ddf89a79394b
Autor:
Federica Francescangeli, Maria Laura De Angelis, Rachele Rossi, Giovanni Sette, Adriana Eramo, Alessandra Boe, Ombretta Guardiola, Tao Tang, Shi-Cang Yu, Gabriella Minchiotti, Ann Zeuner
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Chemotherapy is the mainstay for the treatment of non-small cell lung cancer (NSCLC). However, NSCLC cells are either intrinsically chemoresistant or rapidly develop therapy resistance. Cancer stem cells (CSCs) are widely recognized as the cell popul
Externí odkaz:
https://doaj.org/article/7c7e41a2a4654a0b8288753f8239a4c2
Autor:
Federica Francescangeli, Paola Contavalli, Maria Laura De Angelis, Silvia Careccia, Michele Signore, Tobias Longin Haas, Federico Salaris, Marta Baiocchi, Alessandra Boe, Alessandro Giuliani, Olga Tcheremenskaia, Alfredo Pagliuca, Ombretta Guardiola, Gabriella Minchiotti, Lidia Colace, Antonio Ciardi, Vito D’Andrea, Filippo La Torre, JanPaul Medema, Ruggero De Maria, Ann Zeuner
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-17 (2020)
Abstract Background Quiescent/slow cycling cells have been identified in several tumors and correlated with therapy resistance. However, the features of chemoresistant populations and the molecular factors linking quiescence to chemoresistance are la
Externí odkaz:
https://doaj.org/article/00bd58b74b414a74be068d6e8d3ce09f
Autor:
Sabrina Mariotti, Antonio Capocefalo, Maria Vincenza Chiantore, Angelo Iacobino, Raffaela Teloni, Maria Laura De Angelis, Alessandra Gallinaro, Maria Franca Pirillo, Martina Borghi, Andrea Canitano, Zuleika Michelini, Melissa Baggieri, Antonella Marchi, Paola Bucci, Paul F. McKay, Chiara Acchioni, Silvia Sandini, Marco Sgarbanti, Fabio Tosini, Antonio Di Virgilio, Giulietta Venturi, Francesco Marino, Valeria Esposito, Paola Di Bonito, Fabio Magurano, Andrea Cara, Donatella Negri, Roberto Nisini
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Antibodies targeting Receptor Binding Domain (RBD) of SARS-CoV-2 have been suggested to account for the majority of neutralizing activity in COVID-19 convalescent sera and several neutralizing antibodies (nAbs) have been isolated, characterized and p
Externí odkaz:
https://doaj.org/article/deb1a8e69f9a46ab867a549c64791528
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-3 (2020)
Abstract Severe coronavirus disease 2019 (COVID-19) causes a hyperactivation of immune cells, resulting in lung inflammation. Recent studies showed that COVID-19 induces the production of factors previously implicated in the reawakening of dormant br
Externí odkaz:
https://doaj.org/article/fbed7bd566f44bef8ec4c9ecc6d0d7a4